EULAR press releases

EULAR news archive

News of October 2018

12. Oct. 2018

World Arthritis Day 2018: The press release

On World Arthritis Day ‘Don’t Delay, Connect Today’ Campaign educates on the importance of early diagnosis of rheumatic diseases.

7. Oct. 2018

EULAR Brussels Conference 2018

Get ready to join the EULAR Brussels Conference over livestream on Tuesday, 9 October!

News of July 2018

13. Jul. 2018

EULAR Recommendations on the effect of exercise and physical activity promotion in people with rheumatoid arthritis, spondyloarthritis and osteoarthritis

12th July, 2018, Kilchberg, Switzerland – The European League Against Rheumatism, EULAR, has published a set of recommendations for health professionals regarding physical activity in people with rheumatoid arthritis, spondyloarthritis and osteoarthritis. The recommendations report in detail on the meta-analysis that was performed to answer the question on the effectiveness of physical activity interventions.

News of June 2018

15. Jun. 2018

Press Release: Studies provide new insights into the role of sleep in chronic pain

Amsterdam, The Netherlands, 15 June 2018: The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR 2018) provide insight into the role of sleep in chronic pain. The first study demonstrates a predictive role of sleep problems for chronic pain1 and the second provides insight into chronic pain and sleep in adolescents.

15. Jun. 2018

Press Release: Study suggests siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome

Amsterdam, The Netherlands, 15 June 2018: The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate an increased risk of acute coronary syndrome (ACS) in siblings of individuals with rheumatoid arthritis (RA), suggesting shared susceptibility between the two diseases.

15. Jun. 2018

Press Release: Obesity in women and current smoking in men predict lack of remission in early rheumatoid arthritis

Amsterdam, The Netherlands, 15 June 2018: The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) report that obesity in women and current smoking in men were the strongest predictors of not achieving remission in early rheumatoid arthritis (RA) within a year.

15. Jun. 2018

Press Release: Gout in the elderly linked to higher risk of dementia

Amsterdam, The Netherlands, 15 June 2018: The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) suggest that gout is associated with a 17-20% higher risk of dementia in the elderly.

15. Jun. 2018

Press Release: Gum disease may be a key initiator of rheumatoid arthritis related autoimmunity

Amsterdam, The Netherlands, 15 June 2018: The results of a study presented at the Annual European Congress of Rheumatology (EULAR 2018) demonstrates increased levels of gum disease, and disease-causing bacteria, in individuals at risk of rheumatoid arthritis (RA).

15. Jun. 2018

Press Release: Rates of depression and anxiety may correlate with disease activity in early rheumatioid arthritis

Amsterdam, The Netherlands, 15 June 2018: The results of a study to be presented at the Annual European Congress of Rheumatology (EULAR 2018) suggest that rates of anxiety and depression in patients with rheumatoid arthritis correlate with measures of disease activity over the first year following diagnosis.

15. Jun. 2018

Press Release: Obesity in childhood and adulthood shown to increase risk of knee and hip osteoarthritis

Amsterdam, The Netherlands, 15 June 2018: The results of a study to be presented at the Annual European Congress of Rheumatology (EULAR 2018) suggest childhood and adult obesity increase the risk of developing hip osteoarthritis (OA) and knee OA but not hand OA.

14. Jun. 2018

Press Release: Onset of depressive symptoms significantly associated with disease severity in patients with knee osteoarthritis

Amsterdam, The Netherlands, 14 June 2018: The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate that among individuals with radiographic knee osteoarthritis (OA), decreased physical performance and greater structural disease severity are associated with a higher risk of experiencing depressive symptoms.

14. Jun. 2018

Press Release: Significant increase in self-harm attempts following ankylosing spondylitis diagnosis

Amsterdam, The Netherlands, 14 June 2018: The results of a population study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate a significantly increased rate of self-harm attempts in inflammatory arthritis (IA), particularly following a diagnosis of Ankylosing Spondylitis (AS).

14. Jun. 2018

Press Release: Clinical advances in systemic lupus erythematosus

Amsterdam, The Netherlands, 14 June 2018: The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate exciting advances for individuals suffering from systemic lupus erythematosus (SLE).1,2 The first is a phase II clinical study of a promising oral treatment, baricitinib.1 The second demonstrates the effective use of the shingles vaccine* in SLE patients who are particularly prone to this infection.

14. Jun. 2018

Press Release: Rheumatoid arthritis in pregnancy associated with low birth weight and premature birth

Amsterdam, The Netherlands, 14 June 2018: The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate that pregnancies in women with rheumatoid arthritis are associated with premature delivery and low birth weight.

14. Jun. 2018

Press Release: Youth-R-Coach: A peer-to-peer program for young people suffering with chronic disease

Amsterdam, The Netherlands, 14 June 2018: The details of a youth project presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate how, by empowering patients to become ‘experts-by-experience’, young people can give support to peers as well as provide insights into living with a chronic illness as a young person.

14. Jun. 2018

Press Release: Daily text message may improve adherence and treatment outcomes in patients with gout

Amsterdam, The Netherlands, 14 June 2018: The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate significant improvements in adherence and clinical outcomes in gout patients who received a daily text message to remind them to take allopurinol.

14. Jun. 2018

Press Release: Combining NSAIDs and TNF inhibitors may reduce radiographic progression in ankylosing spondylitis

Amsterdam, The Netherlands, 14 June 2018: The results of a cohort study presented at the Annual European Congress of Rheumatology (EULAR 2018) showed that, in patients with ankylosing spondylitis (AS) taking tumour necrosis factor (TNF) inhibitors, the addition of non-steroidal anti-inflammatory drugs (NSAIDs) was associated with significantly less radiographic progression in a dose-related manner at four years.

14. Jun. 2018

Press Release: One year anniversary: EULAR Campaign

Amsterdam, The Netherlands, 14 June 2018: The European League Against Rheumatism (EULAR) today celebrated one year since the launch of its campaign, ‘Don’t Delay, Connect Today’, which was launched in June 2017 in Madrid, Spain. Now active in over twenty countries in Europe, and with more countries set to launch the campaign in the second half of the year, ‘Don’t Delay, Connect Today’ is gaining impact across all audiences, including at the political level in Europe.

13. Jun. 2018

Press Release: No difference in malignancy rates seen between tocilizumab and TNF inhibitors in patients with rheumatoid arthritis

Amsterdam, The Netherlands, 13 June 2018: The results of a study presented at the Annual European Congress of Rheumatology (EULAR 2018) examined rates of malignancy in patients with rheumatoid arthritis (RA), excluding non-melanoma skin cancer (NMSC), and found no difference between those newly treated with tocilizumab (TCZ) versus TNF inhibitors (TNFi).

13. Jun. 2018

Press Release: Early, intensive treatment of rheumatoid arthritis provides long-term benefits and may normalise mortality rates

Amsterdam, The Netherlands, 13 June 2018: The results of a 23-year, follow-up study presented today at the Annual European Congress of Rheumatology (EULAR 2018) suggest early, intensive treatment of rheumatoid arthritis has long-term benefits including the normalisation of mortality to levels consistent with the general population.

13. Jun. 2018

Press Release: Zoledronic acid shows no effect on knee pain or bone marrow lesions in knee osteoarthritis after two years

Amsterdam, The Netherlands, 13 June 2018: The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) show that a one-yearly infusion of zoledronic acid (ZA) did not significantly reduce knee pain or bone marrow lesion (BML) size overall in knee osteoarthritis patients over two years. However, it may have symptomatic benefit in milder disease.

13. Jun. 2018

Press Release: Canakinumab shown to reduce rates of gout in atherosclerosis by more than half

Amsterdam, The Netherlands, 13 June 2018: The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate that canakinumab significantly reduced the rate of gout by more than half compared to placebo, regardless of baseline serum urate level.

13. Jun. 2018

Press Release: New treatment lenebasum shows promise for diffuse cutaneous systemic sclerosis (dcSSc)

Amsterdam, The Netherlands, 13 June 2018: The results of an open label extension of a phase II study presented today at the Annual European Congress of Rheumatology (EULAR 2018) demonstrate that lenabasum continues to have acceptable safety and tolerability in diffuse cutaneous systemic sclerosis (dcSSc) with no severe or serious adverse events (AE).

13. Jun. 2018

Press Release: Launch of the EULAR Strategy 2018–2023

Amsterdam, The Netherlands, 13th June 2018: The European League Against Rheumatism (EULAR) has today presented its five-year strategy for the period 2018-2023 at the Annual European Congress of Rheumatology 2018. The strategy is the third strategic cycle in developing excellence in rheumatology in six areas of focus: Education, the annual congress, quality of care, research, advocacy and the internal organisation of EULAR.

13. Jun. 2018

Press Release: Gene signatures and biomarkers predict onset of rheumatoid arthritis in at-risk individuals

Amsterdam, The Netherlands, 13 June 2018: The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR 2018) provide insight into molecular changes prior to the onset of arthritis which could inform future novel diagnostics and early therapeutic interventions.

13. Jun. 2018

Press Release: Frequency of joint replacements halved in rheumatoid arthritis patients between 1997-2010

Amsterdam, The Netherlands, 13 June 2018: The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR 2018) investigate joint replacement procedures in rheumatoid arthritis (RA) patients.1,2 The first study demonstrates that joint replacement procedures have significantly reduced in RA patients in the past decade1 and the second investigates the impact of biologic therapies on this change using the British Society for Rheumatology Biologics Registry for Rheumatoid Arthritis (BSRBR/RA).

13. Jun. 2018

Press Release: NSAIDs shown to have casual role in cardiovascular risk of patients with osteoarthritis

Amsterdam, The Netherlands, 13 June 2018: The results of a study presented today at the Annual European Congress of Rheumatology (EULAR 2018) suggest that over two thirds of the increased cardiovascular risk associated with osteoarthritis is linked to the use of non-steroidal anti-inflammatory drugs (NSAIDs).

13. Jun. 2018

EULAR School of Rheumatology: Launch of online 'learning landscape' and new educational offers

The EULAR School of Rheumatology membership for EUR 30 per annum provides access to the latest learning enviornment and content in rheumatology.

News of May 2018

14. May. 2018

New: EULAR Recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis

14th May, 2018, Kilchberg, Switzerland – The European League Against Rheumatism, EULAR, has published a set of recommendations, designed to help health professionals implement approaches to pain management in inflammatory arthritis and osteoarthritis patients. The aim is to reduce pain and the burden on the individual and society.

News of April 2018

17. Apr. 2018

Press release: EULAR Recommendations for the management of Behҫet’s syndrome

EULAR has published a set of recommendations, which look at the management of Behçet’s syndrome.

News of January 2018

29. Jan. 2018

Press Release: EULAR Recommendations for the use of imaging in large vessel vasculitis in clinical practise

A EULAR task force has formulated 12 recommendations which have been published in its journal, The Annals of Rheumatic Diseases, the leading scientific journal in rheumatology with an impact factor of 12.811.

News of December 2017

18. Dec. 2017

EULAR in 2017: A year of impact on rheumatology and on humanity

EULAR has set a new course in 2017 opening the door to an age of dynamic maturity for the world of rheumatology – with positive impact on societies, everywhere.

7. Dec. 2017

Press release: EULAR Recommendations

Actively optimising patient care in rheumatism: Contribution to and dissemination of key scientific findings in rheumatology are set out in the EULAR Recommendations – and translated into lay versions as well as local languages across Europe

News of October 2017

17. Oct. 2017

Press release: Investment beyond 2020

EULAR has called on the European Commission to maintain the EU’s position as global leader in health research. This includes continuing investment in research and developing a forward-looking agenda beyond the current research framework programme, Horizon 2020.

News of July 2017

6. Jul. 2017

EULAR School of Rheumatology Launch A 'Benefit to Humanity'

New ‘one roof structure’ for EULAR educational offerings, services and products gives international rheumatology community access to cutting-edge continued professional development.

5. Jul. 2017

New Editor for Annals of the Rheumatic Diseases

BMJ, a leading healthcare knowledge provider, is pleased to announce Josef Smolen as the new editor of Annals of the Rheumatic Diseases (ARD).

ARD is the top ranked journal in the field of rheumatology with an impact factor of 12.811.

News of June 2017

26. Jun. 2017

EULAR contributes 70 years to the field of RMDs

EULAR has released a press release to international media circles in celebration of its 70th anniversary.

Read the text and comments from EULAR President Prof. Gerd Burmester and President-elect Prof. Johannes Bijlsma.

22. Jun. 2017

EULAR Campaign: Don't Delay, Connect Today

The EULAR Campaign, Don't Delay, Connect Today, encompasses the three pillars of the association, scientific, health professionals and patient organisations. It was launched in Madrid, Spain, in mid-June.

Find information toolkits on the dedicated webpage, watch the video and get involved!

14. Jun. 2017

POSTMENOPAUSAL WOMEN AT RISK OF FRACTURES COULD BE IDENTIFIED THROUGH GENETIC PROFILING

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed for the first time that genetic markers, identified in previous research as being linked to the development of osteoporosis, are also associated with the risk of fragility fractures in postmenopausal women.

14. Jun. 2017

NEW STUDY SHOWS FOR FIRST TIME LINK BETWEEN PASSIVE SMOKING IN CHILDHOOD AND RHEUMATOID ARTHRITIS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference confirmed the link between active smoking and the risk of developing rheumatoid arthritis (RA). However, interestingly, it also suggested for the first time that in smokers, exposure to tobacco early in life through passive smoking in childhood significantly increased this risk.

14. Jun. 2017

NEW RELAPSE PREDICTION TOOL REDUCES COST OF RHEUMATOID ARTHRITIS TREATMENT

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 have shown that the combined use of two measurements to accurately predict the risk of relapse in patients with rheumatoid arthritis (RA) allows successful dose reduction (tapering) of their disease modifying anti-rheumatic drugs (DMARDs). This in turn increases the cost-effectiveness of each DMARD treatment.

14. Jun. 2017

NEW EFFECTIVE TREATMENTS FOR PSORIATIC ARTHRITIS PATIENTS

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference revealed promising data supporting two new drug classes for the treatment of psoriatic arthritis (PsA).

14. Jun. 2017

GENES EXPLAIN HIGHER PREVALENCE OF CARDIOVASCULAR DISEASE IN CHRONIC IMMUNE MEDIATED INFLAMMATORY DISEASE PATIENTS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 represent an important step towards characterising the genetic basis of cardiovascular disease (CVD) risk in chronic immune-mediated inflammatory diseases (IMID).

14. Jun. 2017

EXCESS RISK OF CARDIOVASCULAR EVENTS IN RHEUMATOID ARTHRITIS PATIENTS DECREASED SINCE START OF 21ST CENTURY

The results of a meta-analysis presented for the first time today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that the excess risk of cardiovascular events in rheumatoid arthritis (RA) patients relative to the general population has significantly decreased since the year 2000.

14. Jun. 2017

EDUCATION FOR PEOPLE WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES AND EMPLOYERS CAN IMPROVE ABILITY TO WORK

The results of an educational programme implemented by the Galician Rheumatology League (LRG), presented today at the Annual European Congress of Rheumatology (EULAR) 2017, showed that providing education and advice to people with rheumatic and musculoskeletal disease (RMD) and their employers can make a significant difference to the ability to work.

14. Jun. 2017

BIOSIMILAR CONCERNS OF RHEUMATOLOGY PATIENTS BEING ADDRESSED BY NATIONAL PROGRAMME

To address the fear and insecurity expressed by rheumatology patients on being switched from a biologic to a biosimilar treatment for their arthritis, the Danish Rheumatism Association has participated in a national programme designed to ensure patients received independent information about biosimilars, along with closer monitoring of prescriptions to provide reassurance about their safety. The results of this initiative were presented today at the Annual European Congress of Rheumatology (EULAR) 2017.

14. Jun. 2017

PERSISTENT PAIN SHOWS UP INEFFICIENCY OF CURRENT PSORIATIC ARTHRITIS (PsA) TREATMENT

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference have highlighted limitations in the current treatment of patients with Psoriatic Arthritis (PsA).

14. Jun. 2017

NURSES CRUCIAL IN IMPROVING UPTAKE OF POTENTIALLY LIFE-SAVING VACCINE IN VULNERABLE RHEUMATIC PATIENTS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that implementing a vaccination programme run by nursing staff dramatically improves pneumococcal vaccination coverage among vulnerable patients with chronic inflammatory rheumatic diseases.

14. Jun. 2017

NEW BLOOD TEST DETECTS STROKE AND HEART ATTACK RISK IN LUPUS PATIENTS WITH NO CARDIOVASCULAR SYMPTOMS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference have shown that a specific biomarker detected in the blood of lupus patients with no symptoms of cardiovascular disease (CVD), thought to be at low risk of CVD based on traditional risk factors, is associated with the presence of atherosclerosis.

14. Jun. 2017

LOW-DOSE CT SCANNING IMPROVES ASSESSMENT OF ANKYLOSING SPONDYLITIS PATIENTS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 showed that low dose computed tomography (LD-CT) is more sensitive than conventional radiographs (X-rays) in the monitoring of disease progression in patients with Ankylosing Spondylitis (AS).

14. Jun. 2017

COGNITIVE BEHAVIOUR THERAPY (CBT) SIGNIFICANTLY REDUCED DEPRESSION AND ANXIETY IN CHRONIC PAIN PATIENTS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 has shown that Acceptance and Commitment Therapy, a form of cognitive behavioural therapy (CBT) that focuses on psychological flexibility and behaviour change, provided a significant reduction in self-reported depression and anxiety among patients participating in a pain rehabilitation programme.

14. Jun. 2017

BIOLOGICAL DMARD GUIDELINES ASSOCIATED WITH A REDUCED NEED FOR KNEE AND HIP REPLACEMENTS IN RA PATIENTS

The results of a Danish study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that the incidence of total knee replacements (TKR) carried out on patients with rheumatoid arthritis (RA) started to decrease after the introduction of biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) to national treatment guidelines.

14. Jun. 2017

PREVIOUS BACTERIAL INFECTION INCREASES RISK OF NEWLY-DIAGNOSED SJÖGREN’S SYNDROME

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 have shown a link between newly-diagnosed Sjögren’s syndrome (SjS) and previous infection with nontuberculous mycobacteria (NTM).

14. Jun. 2017

NEW TOOLS HELP EARLY DIAGNOSIS OF SYSTEMIC SCLEROSIS

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference highlight the use of two new tools, which can potentially play a pivotal role in the early diagnosis of Systemic Sclerosis (SSc).

14. Jun. 2017

NEW IMAGING TECHNIQUE MAY HELP IDENTIFY JOINT INFLAMMATION IN CHILDREN EARLIER AND WITH GREATER CONFIDENCE

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 have confirmed that Fluorescence Optical Imaging (FOI), a technique used to visualise inflammation in arthritic joints, is as effective as ultrasound with Power Doppler (US / PD) at monitoring response to treatment in juvenile idiopathic arthritis (JIA). FOI was also found to be more effective than US / PD at detecting inflammation in the absence of symptoms and signs.

14. Jun. 2017

NEW DATA SUGGEST NO INCREASED CANCER RISK FOR RA PATIENTS PRESCRIBED BIOLOGICAL DMARDS

The results of two studies presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference should reassure rheumatologists regarding the risk of cancer from the use of biological disease modifying anti-rheumatic drugs (bDMARDs), including anti-TNF treatment, in patients with rheumatoid arthritis (RA).

14. Jun. 2017

NEW CLASS OF DRUG SIGNIFICANTLY REDUCES SPINE FRACTURE RISK IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS

The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that, in postmenopausal women with osteoporosis, 12 months treatment with romosozumab was associated with rapid and large reductions in their risk of a vertebral fracture compared to placebo.

14. Jun. 2017

EARLY THERAPEUTIC INTERVENTION FOR PRE-RHEUMATOID ARTHRITIS (PRE-RA) PATIENTS SIGNIFICANTLY REDUCES RISK OF RA

The results of a meta-analysis presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference has demonstrated that early therapeutic intervention in patients with so-called “pre-rheumatoid arthritis” (pre-RA) significantly reduces the risk of the occurrence of rheumatoid arthritis (RA) in these patients at 52 weeks or more.

14. Jun. 2017

CONTINUING ANTI-TNF TREATMENT WITH CZP FOR RA DURING PREGNANCY: NO OR NEGLIGIBLE PLACENTAL TRANSFER

The results of a pharmacokinetic study presented at the Annual European Congress of Rheumatology (EULAR) 2017 showed no or negligible placental transfer of the anti-TNF drug certolizumab pegol (CZP) from mothers to infants during pregnancy.

14. Jun. 2017

BODY FAT AND WAIST SIZE LINKED TO INCREASED RISK OF DEVELOPING RHEUMATOID ARTHRITIS IN WOMEN

The results of a population study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 showed that, in women, being overweight or obese, as defined by body mass index (BMI*), abdominal obesity and a higher body fat percentage was associated with a higher risk of developing rheumatoid arthritis (RA).

1. Jun. 2017

EULAR launches 'RheumaMap’ in EU Parliament in Brussels

In a meeting of the Interest Group on Rheumatic and Musculoskeletal Diseases (RMDs), the “Research Roadmap to transform the lives of people with Rheumatic and Musculoskeletal Diseases” was launched in the European Parliament.